Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Bora Pharmaceuticals

Market Cap: NT$84.4b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

Zhejiang Wecome Pharmaceutical

Market Cap: CN¥3.4b

Engages in the research and development, production, and sale of modern traditional Chinese and western medicine in China.

Henan Lingrui Pharmaceutical

Market Cap: CN¥12.5b

Produces and sells medicines in China.

Shanghai Junshi Biosciences

Market Cap: HK$42.0b

A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China.

Vivo Bio Tech

Market Cap: ₹794.4m

Provides drug development and discovery services to pharmaceutical and biotech companies worldwide.

Hinova Pharmaceuticals

Market Cap: CN¥5.2b

A clinical-stage pharmaceutical company, engages in the development and production of therapeutics for cancers and metabolic syndromes.

May & Baker Nigeria

Market Cap: ₦28.0b

May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria.

Citi Pharma

Market Cap: PK₨22.6b

Engages in the manufacture and sale of pharmaceutical, medical chemical, and botanical products in Pakistan.

Eisai

Market Cap: JP¥1.4t

Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan.

Shandong Sito Bio-technology

Market Cap: CN¥2.8b

Researches, develops, and produces steroid biomedicine intermediates.

Hyundai ADM Bio

Market Cap: ₩118.4b

A contract research organization, provides clinical services in Asia.

Deva Holding

Market Cap: ₺13.8b

Manufactures, markets, and sells pharmaceutical products in Turkey.

Kangstem Biotech

Market Cap: ₩140.1b

A biopharmaceutical company, develops stem cell therapeutic products for rare and incurable diseases.

AprilBioLtd

Market Cap: ₩590.1b

AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics.

Porton Pharma Solutions

Market Cap: CN¥13.3b

Provides contract development and manufacturing organization (CDMO) solutions for small molecules, tides, biologics, and conjugates from pre-clinical to commercial.

Parnax Lab

Market Cap: ₹1.4b

Engages in the manufacture and export of pharmaceutical formulations in India and internationally.

Venmax Drugs and Pharmaceuticals

Market Cap: ₹116.0m

Engages in the business of pharmaceutical products, drug intermediaries, and API’s.

Albert David

Market Cap: ₹4.4b

Manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally.

Dongwha Pharm.Co.Ltd

Market Cap: ₩176.0b

Manufactures and sells pharmaceutical products in South Korea.

Shenzhen Kangtai Biological Products

Market Cap: CN¥18.3b

Shenzhen Kangtai Biological Products Co., Ltd.

AcouSort

Market Cap: SEK 67.5m

A technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets.

Lipigon Pharmaceuticals

Market Cap: SEK 85.4m

Develops drugs for lipid related diseases in Sweden.

GeneOne Life Science

Market Cap: ₩194.3b

A biopharmaceutical company, engages in the research, development, and contract manufacturing of nucleic acid-based biopharmaceuticals.

Corline Biomedical

Market Cap: SEK 361.2m

Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications.

Galderma Group

Market Cap: CHF 32.1b

Operates as a dermatology company worldwide.

Roche Holding

Market Cap: CHF 218.8b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Novakand Pharma

Market Cap: SEK 31.0m

Develops drugs for inflammatory diseases and cancer in Sweden and internationally.

Sotac Pharmaceuticals

Market Cap: ₹1.2b

Engages in the production, manufacturing, processing, and sale of various pharmaceutical products in India.

MAIA Biotechnology

Market Cap: US$52.8m

MAIA Biotechnology, Inc., together with its subsidiaries, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer.

Xbrane Biopharma

Market Cap: SEK 626.2m

A biotechnology company, engages in the development, manufacture, and sale of biosimilars.

IO Biotech

Market Cap: US$104.1m

A clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform.

C21 Investments

Market Cap: CA$61.2m

An integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States.

Disc Medicine

Market Cap: US$2.2b

A clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States.

Mountain Valley MD Holdings

Market Cap: CA$5.3m

A biotech company, focused on advancing solutions to optimize human, animal, and plant health in Canada.

Annovis Bio

Market Cap: US$42.7m

A clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States.

BSF Enterprise

Market Cap: UK£3.3m

Develops and commercializes cutting-edge tissue-engineered solutions.